Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM

Clinical trial NCT06762223 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06762223
Sponsor: Xiqiao Zhou
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Metabolic Dysfunction-associated Steatotic Liver Disease Type 2 Diabetes Mellitus

Start date: 2024-12-31
Primary completion: 2026-12-31
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.